Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 6Unknown 3Withdrawn 2Terminated 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 1Breast Neoplasms 1Bites and Stings 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Levobupivacaine × Clear all
NCT03811262 2022-05-23

Comparison of Erector Spinae Plane Block With PECS II Block in Patients Undergoing Breast Cancer Surgery

University of Padova

Phase NA Withdrawn
Breast

Breast Neoplasms

NCT02121951 2018-04-10

QLB

National Cancer Institute, Egypt

Phase 4 Withdrawn

Bites and Stings, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡